These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35433730)

  • 1. A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive Dermatomyositis.
    Ouyang ZM; Lin JZ; Tang AJ; Yang ZH; Yang LJ; Wei XN; Li QH; Liang JJ; Zheng DH; Guo BP; Zhao G; Han Q; Dai L; Mo YQ
    Front Med (Lausanne); 2022; 9():860798. PubMed ID: 35433730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Involvement is Associated with Higher Risk of Rapidly Progressive Interstitial Lung Disease and Mortality in Anti-Melanoma Differentiation-Associated Gene 5 Antibody- Positive Dermatomyositis.
    Yang X; Cui X; Yang X; Ren B; Cheng X; Zhao X; Liu S; Tian T; Zhao H; Qu L; Li X
    J Inflamm Res; 2024; 17():3101-3113. PubMed ID: 38774443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study.
    Wu W; Xu W; Sun W; Zhang D; Zhao J; Luo Q; Wang X; Zhu F; Zheng Y; Xue Y; Wan W; Wu H; Han Q; Ye S
    Rheumatology (Oxford); 2021 Dec; 61(1):230-239. PubMed ID: 33764398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease.
    Gui X; Li W; Yu Y; Zhao T; Jin Z; Meng K; Wang R; Shi S; Yu M; Ma M; Chen L; Luan W; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Cao M; Dai J; Cai H; Huang M; Xiao Y
    Front Immunol; 2022; 13():978708. PubMed ID: 36211445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ground-glass opacity score predicts the prognosis of anti-MDA5 positive dermatomyositis: a single-centre cohort study.
    Liu L; Zhang Y; Wang C; Guan W; Zhang X; Zhang L; He Y; Hu W; Liu S; Li T
    Orphanet J Rare Dis; 2023 Jul; 18(1):208. PubMed ID: 37480130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Computed Tomography Radiomics-Based Prediction Model on Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis.
    Xu W; Wu W; Zheng Y; Chen Z; Tao X; Zhang D; Zhao J; Wang K; Guo B; Luo Q; Han Q; Zhou Y; Ye S
    Front Med (Lausanne); 2021; 8():768052. PubMed ID: 34912828
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease.
    Gao Y; Zhao Q; Xie M; Yan X; Li Y; Zhang X; Wu H; Dai J; Cao M; Cai H
    Cytokine; 2020 Nov; 135():155209. PubMed ID: 32738770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Predictive Model for the Prognosis of MDA5
    Niu Q; Zhao LQ; Ma WL; Xiong L; Wang XR; He XL; Yu F
    Front Med (Lausanne); 2022; 9():908365. PubMed ID: 35783655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study.
    Li J; Wang S; Zheng J; Li Q; Li J; Lu L
    Clin Rheumatol; 2023 Feb; 42(2):453-462. PubMed ID: 36301369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Effective Lung Ventilation Area Ratio Based on CT Image Analysis Is a New Index to Predict the Shorter Outcome of Anti-melanoma Differentiation-Associated Protein 5 Positive Dermatomyositis Associated Interstitial Lung Disease: A Single-Center Retrospective Study.
    Wang C; Du J; Mei X; Guo L; Li F; Luo H; Li F
    Front Med (Lausanne); 2021; 8():728487. PubMed ID: 34692722
    [No Abstract]   [Full Text] [Related]  

  • 11. Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease.
    Lyu W; Zhou Y; Zhuang Y; Liu Y; Cao M; Xin X; Wu H; Wang J; Meng F; Cai H; Dai J
    Clin Exp Rheumatol; 2020; 38(6):1068-1074. PubMed ID: 31994487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody.
    Jiang L; Wang Y; Peng Q; Shu X; Wang G; Wu X
    Clin Rheumatol; 2019 Jun; 38(6):1655-1663. PubMed ID: 30739212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease.
    Zhao S; Ma X; Zhang X; Jin Z; Hu W; Hua B; Wang H; Feng X; Sun L; Chen Z
    Mod Rheumatol; 2022 Feb; 32(2):373-379. PubMed ID: 34894256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients.
    Yang Q; Li T; Zhang X; Lyu K; Wu S; Chen Y; Liu S; Yu Z
    Orphanet J Rare Dis; 2021 Jan; 16(1):58. PubMed ID: 33516242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis.
    Gui X; Ma M; Ding J; Shi S; Xin X; Qiu X; Zhang Y; Qiu Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
    Rheumatology (Oxford); 2021 Aug; 60(8):3913-3922. PubMed ID: 33501503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
    Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis.
    Cao H; Xia Q; Pan M; Zhao X; Li X; Shi R; Zhou M; Ding X; Kuwana M; Zheng J
    J Rheumatol; 2016 Sep; 43(9):1735-42. PubMed ID: 27307530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome.
    Ding Y; Ge Y
    Ther Adv Chronic Dis; 2022; 13():20406223221098128. PubMed ID: 35586303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.